Guanmo B. Liu
Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The evolving landscape of the Warburg effect in gastric cancer: From molecular mechanisms to targeted therapy.
Journal: Clinical and translational medicine
Published: May 19, 2026
Advancements in targeted therapy for gastric cancer.
Journal: Therapeutic advances in gastroenterology
Published: January 11, 2026
Insights in efficacy of simple oral nutritional supplements after gastrectomy for gastric cancer.
Journal: Hepatobiliary surgery and nutrition
Published: November 02, 2025
Application value of gastric contrast ultrasonography in gastric tumors.
Journal: Insights into imaging
Published: July 31, 2025
OTUB2 induces M2 tumor-associated macrophage polarization and increases CD274 expression in gastric cancer cells to aggravate the progression of gastric cancer.
Journal: Cell death & disease
Published: June 11, 2025
Perioperative Oral Immunonutrient Regulation of Intestinal Barrier and Gut Microbiota in Patients with Gastric Cancer, a Randomized Controlled Clinical Trial.
Journal: Biomedicines
Published: May 15, 2025
Biomarker-based and interpretable machine learning framework for predicting pathological stage in gastric cancer: A retrospective analysis.
Journal: Digital health
Published: May 07, 2025
The impact of diet and gut microbiota on development, treatment, and prognosis in prostate cancer.
Journal: Frontiers in nutrition
Published: May 01, 2025
Comprehensive analysis of single-cell and bulk RNA sequencing data unveils antigen-presenting and processing fibroblasts and establishes a predictive model in gastric cancer.
Journal: Cancer cell international
Published: March 11, 2025
Case Report: Neoadjuvant therapy with ripretinib for gastrointestinal stromal tumor: a case report.
Journal: Frontiers in pharmacology
Published: February 09, 2025
Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer" [Eur J Cancer 180 (2023) 184-185].
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 03, 2024
Last Updated: 09/26/2026